IL1B and type 2 diabetes mellitus: In the present study, we have demonstratedthat in type 2 diabetes, there is an increased mRNA expression of resistin,along with significant increases in TNF-α, IL-6, and Il-1β mRNA expression bythe peripheral circulating mononuclear cells.